You Searched For "vaccine stocks" and got 20 results
Sort By:
2 mins read
Health stocks are tumbling after Trump's appointment of vaccine skeptic RFK Jr.
Vaccine stocks have struggled since RFK Jr.'s appointment to health secretary, with Moderna and Pfi…
Kelly Cloonan
2 mins read
The stock market's Trump honeymoon is turning sour
More than half of the stock market's post-Trump-election rally has been erased.
Filip De Mott
1 min read
Stock market today: Indexes tank as data paints a negative picture for the economy
Stock indexes tanked Thursday as new data shows jobless claims are on the rise while manufacturing …
Kelly Cloonan
2 mins read
Stock market today: Dow soars 555 points as strong economic data calms recession worries
Indexes rose Thursday as investors reacted to a surprisingly strong increase in retail sales and lo…
Kelly Cloonan
1 min read
Moderna stock tumbles 21% as earnings show people aren't getting as many COVID shots
Moderna lowered its annual sales forecast as sales of its COVID-19 vaccine dropped by 37%, fueled b…
Kelly Cloonan
2 mins read
Biological E, Bharat Biotech together sitting on stockpile of 250 million COVID vaccine doses
stockpile of 50 million doses of Covaxin. Dr Vikram Paradkar, Executive Vice President (M…
PTI
2 mins read
China is gunning for the chief scientist of its COVID vaccine project, accusing him of 'serious discipline and law violations'
Yang Xiaoming was kicked from the National People's Congress earlier this month. He was in charge o…
Matthew Loh
1 min read
Novavax stock plunges 25% after the COVID-19 vaccine maker warns it could go out of business
Novavax shares sank after the COVID-19 vaccine maker warned it has "substantial doubt" about its ab…
Zinya Salfiti
1 min read
Moderna extends 2-day gain to 32% after it says Omicron vaccine will be ready in early 2022
"If we have to make a brand new vaccine, I think that's going to be early 2022 before that's really…
Matthew Fox
2 mins read
Pfizer drops after issuing weaker 2022 outlook, dragging COVID-19 vaccine makers Moderna and Novavax down with it
The drugmaker expects 2022 revenue of $98 billion to $102 billion, which fell below analyst expecta…
Matthew Fox
1 min read
Moderna drops, Arbutus pops after patent ruling means vaccine maker could owe royalties on billions in COVID shot revenue
The patents subject to the court's ruling cover a lipid formulation for nucleic acid delivery, whic…
Matthew Fox
1 min read
Moderna and Novavax pare losses after Supreme Court strikes down Biden's vaccine mandate for private employers
The vaccine mandate was aimed at private companies with more than 100 employees. The ruling upheld …
Carla Mozée
2 mins read
Moderna, BioNTech tumble 19% amid report the EU is looking into COVID vaccine side effects
The EU's drug regulator is looking at reports about skin rash and kidney problems.
Carla Mozée
3 mins read
American corporations could pay to vaccinate the world 10 times over with just their extra profits from 2021
Vaccinating the world would cost about $50 billion, the OECD says. That could be easily paid for fr…
Ben Winck,Andy Kiersz
2 mins read
Moderna, BioNTech plunge as Bernie Sanders slams 'obscene' profits and tells drug makers to share COVID-19 vaccines with the world
"It's time for these pharmaceutical companies to share their vaccines with the world and start cont…
Matthew Fox
1 min read
Retail investors are dumping shares of COVID-19 vaccine makers and piling into antiviral pill maker Merck, data shows
Merck shares have jumped since the drug maker said molnupiravir cuts the risk of COVID hospitalizat…
Carla Mozée
2 mins read
US stocks edge higher as vaccine approval supports gains ahead of Fed's Jackson Hole meeting
The S&P 500 is looking to score a fresh record high in Tuesday's session as investors cheer the FDA…
Carla Mozée
1 min read
Pfizer extends 5-day gain to record territory as US recommends COVID-19 booster shot
Pfizer cleared a massive resistance level last week when it surged above its record high of $47.39 …
Matthew Fox
2 mins read
Moderna was the most-bought stock for retail traders in the week leading up to its 16% single-day plunge
Wall Street analysts appear less keen than retail traders on vaccine makers such as Moderna, after …
Harry Robertson
2 mins read
Novavax surges 23% after scoring COVID-vaccine supply deal with the EU
EU member states may buy up to 200 million doses of Novavax's vaccine through 2023.